Department of Radiation Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA.
Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):754-60. doi: 10.1016/j.ijrobp.2012.05.024. Epub 2012 Jul 3.
To demonstrate the dosimetric advantages of intensity modulated radiation therapy (IMRT) in children with Wilms tumor (WT) undergoing whole-liver (WL) RT.
Computed tomography simulation scans of 10 children, either 3 (3D) or 4-dimensional (4D), were used for this study. The WL PTV was determined by the 3D or 4D liver volumes, with a margin of 1 cm. A total of 40 WL RT plans were performed: 10 each for left- and right-sided WT with IMRT and anteroposterior-posteroanterior (AP-PA) techniques. The radiation dose-volume coverage of the WL planning target volume (PTV), remaining kidney, and other organs were analyzed and compared.
The 95% dose coverage to WL PTV for left and right WT were as follows: 97% ± 4% (IMRT), 83% ± 8% (AP-PA) (P<.01) and 99% ± 1% (IMRT), 94% ± 5% (AP-PA) (P<.01), respectively. When 3D WL PTV was used for RT planning, the AP-PA technique delivered 95% of dose to only 78% ± 13% and 88% ± 8% of 4D liver volume. For left WT, the right kidney V15 and V10 for IMRT were 29% ± 7% and 55% ± 8%, compared with 61% ± 29% (P<.01) and 78% ± 25% (P<.01) with AP-PA. For right WT, the left kidney V15 and V10 were 0 ± 0 and 2% ± 3% for IMRT, compared with 25% ± 19% (P<.01) and 40% ± 31% (P<.01) for AP-PA.
The use of IMRT and 4D treatment planning resulted in the delivery of a higher RT dose to the liver compared with the standard AP-PA technique. Whole-liver IMRT also delivered a significantly lower dose to the remaining kidney.
展示调强放疗(IMRT)在接受全肝(WL)放疗的 Wilms 肿瘤(WT)患儿中的剂量学优势。
本研究使用了 10 名儿童的 CT 模拟扫描,其中 3 名(3D)或 4 名(4D)接受了该研究。WL PTV 由 3D 或 4D 肝体积确定,边界为 1cm。共进行了 40 个 WL RT 计划:10 个左、右侧 WT 分别采用 IMRT 和前后-后前(AP-PA)技术。分析和比较了 WL 计划靶区(PTV)、剩余肾脏和其他器官的辐射剂量-体积覆盖情况。
左、右侧 WT 的 WL PTV 95%剂量覆盖率如下:97%±4%(IMRT),83%±8%(AP-PA)(P<.01)和 99%±1%(IMRT),94%±5%(AP-PA)(P<.01)。当使用 3D WL PTV 进行 RT 计划时,AP-PA 技术仅能将 95%的剂量传递到 78%±13%和 88%±8%的 4D 肝体积。对于左 WT,IMRT 的右肾 V15 和 V10 为 29%±7%和 55%±8%,而 AP-PA 为 61%±29%(P<.01)和 78%±25%(P<.01)。对于右 WT,左肾 V15 和 V10 为 IMRT 时为 0±0 和 2%±3%,而 AP-PA 时为 25%±19%(P<.01)和 40%±31%(P<.01)。
与标准 AP-PA 技术相比,使用 IMRT 和 4D 治疗计划可使肝脏接受更高的放疗剂量。全肝 IMRT 还能显著降低对剩余肾脏的剂量。